FDA Inspection 1068672 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on August 30, 2018 in Hot Springs, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hot Springs, AR (United States)